Intellia Therapeutics (NTLA) Tax Provisions (2015)
Intellia Therapeutics (NTLA) reported Tax Provisions of -$246000.0 for Q4 2015, up 12.77% on a QoQ basis from -$282000.0 in Q3 2015.
Intellia Therapeutics (NTLA) has 1 years of Tax Provisions data on file, last reported at -$246000.0 in Q4 2015.
- Quarterly Tax Provisions changed N/A year-over-year to -$246000.0 in Q4 2015, while the trailing twelve-month figure through Sep 2016 was -$246000.0 (changed N/A YoY) and the FY2015 annual result came in at -$1.0 million, changed N/A from the prior year.
- Tax Provisions advanced to -$246000.0 in Q4 2015 per NTLA's latest filing, from -$282000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at -$102000.0 in Q1 2015 and bottomed at -$382000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -246,000.00 |
| Sep 30, 2015 | -282,000.00 |
| Jun 30, 2015 | -382,000.00 |
| Mar 31, 2015 | -102,000.00 |